大象传媒

Home
University of Bergen
Centre for Cancer Biomarkers CCBIO

R&D Network: Cancer biomarkers and targeted therapy

Thursday October 15th, at 13:00-18:00 in Bergen

CCBIO microscope image of cancer cells
CCBIO microscope image
Photo:
CCBIO

Main content

Moderator of the day: Professor Bj酶rn Tore Gjertsen, Centre for Cancer Biomarkers, University of Bergen/Clinical Trial Unit, Haukeland University Hospital.

Preliminary program:

13:00鈥13:30

Registration, light refreshments and poster set up

13:30鈥13:45

Welcome and update on Oslo Cancer Cluster Incubator
- Ketil Widerberg, general manager Oslo Cancer Cluster and Bj酶rn Klem OCC Incubator

13:45鈥14:05

鈥淪ignalling-targeted therapy鈥
- Prof. Bj酶rn Tore Gjertsen

14:05鈥14:25

鈥淐urrent concepts and challenges in cancer research鈥
- Prof. Lars A. Akslen, Director,Centre for Cancer Biomarkers, University of Bergen

14:25-14.30

5 min break听(for further attendants to the key note lecture to enter)

14:30鈥15:20

International key note (also part of the CCBIO- and BBB-seminars):

鈥Circulating biomarkers in early phase drug development for lung cancer鈥
- Dr Matthew Krebs, Institute of Cancer Sciences, University of Manchester

听

Q&A session

15:20鈥15:30

10 min coffee break

听



15:30鈥16:00

Company updates:

听

听BergenBio
- Jim Lorens, CSO

16:00鈥16:30

Oncology projects - BTO update
- Anders Haugland, managing director听

16:30鈥16:40

Concluding remarks from moderator
- Bj酶rn Tore Gjertsen

16:40鈥18:00听

Young researchers poster session
Networking session/standing dinner with tapas

Please register within 13th of October through

You can find printer friendly version of the

Welcome to all!

Seminar
15.10.2015 - 13.00鈥18.00
Auditorium 4, BB-Building, Jonas Lies vei 91, Bergen
Registration deadline 
13.10.2015 - 15.00
Add to calendar

R&D Network Meetings

The R&D Network Meetings are听Oslo Cancer Cluster麓s signature events for members and associated partners, and are听arranged four to five times annualy.

The purpose with these meetings is to gather people from every member segment, representating the whole value chain, and encourage information exchange and innovative collaborations across diciplines.

The R&D Network Meetings features relevant oncology topics, for example clinical trials or kidney cancer, and several speakers will then highlight the topic from their point of view representing all member segments from basic research to international pharma. After the presentations everyone is encouraged to further network and discussion.

08.10.2015